NCT03626922 2022-06-10
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
NSABP Foundation Inc
Phase 1 Unknown
NSABP Foundation Inc
Shanghai Jiao Tong University School of Medicine
Taichung Veterans General Hospital
National Cancer Institute (NCI)